The Lymphoma Research Foundation has awarded 28 new research grants in 2024, amounting to $3.5 million to cancer researchers who will advance understanding of lymphoma and lay the foundation for improved patient care.
As NIH and NCI funding is negotiated in Congress, Paul W. Thurman felt compelled to crunch some numbers. He compared the U.S.’s cumulative funding for NCI to the funding slated for ICE—the latter of which vastly outweighs the former—and asked whether the funding priorities of the federal government are properly representing the nation’s mortality.
